WuXi AppTec (HKG:2359, SHA:603259) posted 19.2 billion yuan in profit attributable to owners for the first three quarters of 2026, compared with 11.8 billion yuan a year ago.
EPS from continuing and discontinued operations moved to 6.47 yuan from 4.12 yuan year over year, a Monday filing with the Hong Kong Exchange showed.
For the nine months ended Sept. 30, revenue was 45.5 billion yuan versus 32.9 billion yuan previously, the drug research and development company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments